Feline Immunodeficiency Virus: Disease Association Versus Causation in Domestic and Nondomestic Felids

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 6, 2011, Pages 1197-1208

  White, Joanna ^a   Stickney, Alison ^a   Norris, Jacqueline M ^b  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Animals; HIV; Immunodeficiency virus

Indexed keywords

FELINE IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

ANIMAL CARE; ASYMPTOMATIC INFECTION; CAT DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA DETERMINATION; DOG DISEASE; DOMESTIC ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; REVIEW; RNA VIRUS INFECTION; SENSITIVITY AND SPECIFICITY; SYMPTOM; VETERINARY MEDICINE; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, WILD; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; SENTINEL SURVEILLANCE;

EID: 82755162070     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2011.07.003     Document Type: Review

References (95)

1. Pedersen N.C., Ho E.W., Brown M.L., et al. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987, 235(4790):790-793.
2. Bendinelli M., Pistello M., Lombardi S., et al. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clini Microbiol Rev 1995, 8(1):87-112.
3. Taniguchi A., Ishida T., Konno A., et al. Altered mitogen response of peripheral blood lymphocytes in different stages of feline immunodeficiency virus infection. Nihon Juiquaku Zasshi 1990, 52(3):513-518.
4. Lin D.S., Bowman D.D., Jacobson R.H., et al. Suppression of lymphocyte blastogenesis to mitogens in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol 1990, 26(2):183-189.
5. Torten M., Franchini M., Barlough J.E., et al. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol 1991, 65(5):2225-2230.
6. Bishop S.A., Williams N.A., Gruffydd-Jones T.J., et al. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus. AIDS 1992, 6(3):287-293.
7. Lin D.S., Bowman D.D., Jacobson R.H. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections. J Clin Microbiol 1992, 30(1):17-24.
8. Hartmann K., Griessmayr P., Schulz B., et al. Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection. J Feline Med Surg 2007, 9:439-445.
9. Levy J., Crawford C., Hartmann K., et al. 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J Feline Med Surg 2008, 10(3):300-316.
10. Mylonakis E., Paliou M., Lally M., et al. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 2000, 109(7):568-576.
11. Yilmaz G. Diagnosis of HIV infection and laboratory monitoring of its therapy. J Clin Virol 2001, 21(3):187-196.
12. Levy J.K., Crawford P.C., Slater M.R. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats. J Am Vet Med Assoc 2004, 225(10):1558-1561.
13. Levy J.K., Crawford P.C., Kusuhara H., et al. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats. J Vet Intern Med 2008, 22(2):330-334.
14. Crawford P.C., Slater M.R., Levy J.K. Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats. J Am Vet Med Assoc 2005, 226(9):1503-1507.
15. Adams H.M., Vuuren S., Kania A.M., et al. Sensitivity and specificity of a nested polymerase chain reaction for detection of lentivirus infection in lions (Panthera leo). J Zoo Wildl Med 2010, 41:608-615.
16. Browne W., Stryhn H. Introduction to bayesian analysis. Veterinary epidemiologic research 2010, 637-661. VER Inc, Charlottetown (Canada). I. Dahoo, W. Martin, H. H Stryhn (Eds.).
17. Pinches M.D.G., Diesel G., Helps C.R., et al. An update on FIV and FeLV test performance using a bayesian statistical approach. Vet Clin Pathol 2007, 36(2):141-147.
18. Matsumura S., Ishida T., Washizu T., et al. Pathologic features of acquired immunodeficiency-like syndrome in cats experimentally infected with feline immunodeficiency virus. J Vet Med Sci 1993, 55(3):387-394.
19. Muirden A. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus and feline coronavirus in stray cats sent to an RSPCA hospital. Vet Rec 2002, 150(20):621-625.
20. Akhtardanesh B., Ziaali N., Sharifi H., et al. Feline immunodeficiency virus, feline leukemia virus and Toxoplasma gondii in stray and household cats in Kerman-Iran: Seroprevalence and correlation with clinical and laboratory findings. Res Vet Sci 2010, 89(2):306-310.
21. Norris J.M., Bell E.T., Hales L., et al. Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia. J Feline Med Surg 2007, 9(4):300-308.
22. Hitt M.E., Spangler L., McCarville C. Prevalence of feline immunodeficiency virus in submissions of feline serum to a diagnostic laboratory in Atlantic Canada. Can Vet J 1992, 33(11):723-776.
23. Robertson I.D., Robinson W.F., Alexander R., et al. Feline immunodeficiency virus and feline leukaemia virus in cats. Australian Veterinary Practitioner 1990, 20(2):66-69.
24. Hofmann-Lehmann R., Holznagel E., Ossent P., et al. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol 1997, 4(1):33-42.
25. Addie D., Dennis J.M., Toth S., et al. Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec 2000, 146(15):419-424.
26. Shelton G.H., Linenberger M.L., Persik M.T., et al. Prospective hematologic and clinicopathologic study of asymptomatic cats with naturally acquired feline immunodeficiency virus infection. J Vet Intern Med 1995, 9(3):133-140.
27. Ishida T., Taniguchi A., Matsumura S., et al. Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers. Vet Immunol Immunopathol 1992, 35(1-2):15-22.
28. Shaw S.E., Robertson I.D., Robinson W.F., et al. Feline immunodeficiency virus: disease associations. Australian Veterinary Practitioner 1990, 20(4):194-198.
29. Ravi M., Wobeser G.A., Taylor S.M., et al. Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis. Can Vet J 2010, 51(3):271-276.
30. Fujino Y., Horiuchi H., Mizukoshi F., et al. Prevalence of hematological abnormalities and detection of infected bone marrow cells in asymptomatic cats with feline immunodeficiency virus infection. Vet Microbiol 2009, 136(3-4):217-225.
31. Pedersen N.C., Yamamoto J.K., Ishida T., et al. Feline immunodeficiency virus infection. Vet Immunol Immunopathol 1989, 21(1):111-129.
32. Sprague W.S., TerWee J.A., VandeWoude S. Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection. Vet Immunol Immunopathol 2010, 134(1-2):115-121.
33. Sparkes A.H., Hopper C.D., Millard W.G., et al. Feline immunodeficiency virus infection. Clinicopathologic findings in 90 naturally occurring cases. J Vet Intern Med 1993, 7(2):85-90.
34. Hopper C.D., Sparkes A.H., Gruffyd-Jones T.J., et al. Clinical and laboratory findings in cats infected with feline immunodeficiency virus. Vet Rec 1989, 125(13):341-346.
35. Fleming E.J., McCaw D.L., Smith J.A., et al. Clinical, hematologic, and survival data from cats infected with feline immunodeficiency virus: 42 cases (1983-1988). J Am Vet Med Assoc 1991, 199(7):913-916.
36. Kohmoto M., Uetsuka K., Ikeda Y., et al. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain. J Vet Med Sci 1998, 60(3):315-321.
37. Deniz A. Evaluation of clinical findings, some hematological and biochemical findings, and age and sex status in feline immunodeficiency virus (FIV) seropositive cats with clinical symptoms and without clinical symptoms. Turkish Journal of Veterinary & Animal Sciences 2001, 25(4):409-419.
38. Gleich S., Hartmann K. Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. J Vet Intern Med 2009, 23(3):552-558.
39. Shelton G.H., Linenberger M.L. Hematologic abnormalities associated with retroviral infections in the cat. Semin Vet Med Surg (Small Anim) 1995, 10(4):220-233.
40. Hosie M.J., Robertson C., Jarrett O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United-Kingdom. Vet Rec 1989, 125(11):293-297.
41. Tenorio A.P., Franti A.P., Madewell B.R., et al. Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses. Vet Immunol Immunopathol 1991, 29(1-2):1-14.
42. Quimby J.M., et al. Evaluation of the association of Bartonella species, feline herpesvirus 1, feline calicivirus, feline leukemia virus and feline immunodeficiency virus with chronic feline gingivostomatitis. J Feline Med Surg 2008, 10(1):66-72.
43. Dubey J.P., Lappin M.R., Kwok O.C.H., et al. Seroprevalence of Toxoplasma gondii and concurrent Bartonella spp. feline immunodeficiency virus, and feline leukemia virus infections in cats from Grenada, West Indies. J Parasitol 2009, 95(5):1129-1133.
44. O'Neil S.A., Lappin M.R., Reif J.S., et al. Clinical and epidemiological aspects of feline immunodeficiency virus and Toxoplasma gondii coinfections in cats. J Am Anim Hosp Assoc 1991, 27(2):211-220.
45. Dorny P., Speybroeck N., Verstraete S., et al. Serological survey of Toxoplasma gondii, feline immunodeficiency virus and feline leukaemia virus in urban stray cats in Belgium. Vet Rec 2002, 151(21):626-629.
46. Lappin M.R., Marks A., Greene C.E., et al. Effect of feline immunodeficiency virus infection on Toxoplasmosis gondii-specific humoral and cell-mediated immune responses of cats with serological evidence of Toxoplasmosis. J Vet Intern Med 1993, 7(2):95-100.
47. Lappin M.R., George J.W., Pedersen N.C., et al. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996, 82(5):733-742.
48. Davidson M.G., Rottman J.B., English R.V., et al. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol 1993, 143(5):1486-1497.
49. Poli A., Abramo F., Taccini E., et al. Renal involvement in feline immunodeficiency virus infection: a clinicopathological study. Nephron 1993, 64(2):282-288.
50. Poli A., Abramo F., Matteucci D., et al. Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis. Vet Immunol Immunopathol 1995, 46(1-2):13-20.
51. Thomas J.B., Robinson W.F., Chadwick B.J., et al. Association of renal disease indicators with feline immunodeficiency virus infection. J Am Anim Hosp Assoc 1993, 29(4):320-326.
52. Tozon N. Proteinuria in clinical diagnostic of renal disease in cats infected with feline immunodeficiency virus. Slov Vet Res 2000, 37(1/2):53-66.
53. Levy J.K. CVT update: Feline immunodeficiency virus. Kirk's current veterinary therapy XIII: small animal practice 2000, 284-291. Saunders, Philadelphia. J.D. Bonagura (Ed.).
54. Weiner N.J., Goodman J.W., Kimmel P.L. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003, 63(5):1618-1631.
55. Kimmel P.L. The nephropathies of HIV infection: pathogenesis and treatment. Curr Opin Nephrol Hypertens 2000, 9(2):117-122.
56. Arjona A., Escolar E., Soto I., et al. Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects. J Clin Microbiol 2000, 38(9):3448-3449.
57. White J.D., Malik R., Norris J.M., et al. Association between naturally occurring chronic kidney disease and feline immunodeficiency virus infection status in cats. J Am Vet Med Assoc 2010, 236(4):424-429.
58. Podell M., March P.A., Buck W.R., et al. The feline model of neuroAIDS: understanding the progression towards AIDS dementia. J Psychopharmacol 2000, 14(3):205-213.
59. Prosperogarcia O., Herold N., Phillips T.R., et al. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A 1994, 91(26):12947-12951.
60. Phillips T.R., Prospero-Garcia O., Puaoi D.L., et al. Neurological abnormalities associated with feline immunodeficiency virus-infection. J Gen Virol 1994, 75:979-987.
61. Power C., Moench T., Peeling J., et al. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997, 77(4):1175-1185.
62. Power C., Buist R., Johnston J.B., et al. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J Virol 1998, 72(11):9109-9115.
63. Steigerwald E.S., Sarter M., March P., et al. Effects of feline immunodeficiency virus on cognition and behavioral function in cats. J Acquir Immune Defic Syndr 1999, 20(5):411-419.
64. Phillips T.R., Prospero-Garcia O., Wheeler D.W., et al. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol 1996, 2(6):388-396.
65. Dow S.W., Poss M.L., Hoover E.A. Feline immunodeficiency virus-a neurotropic lentivirus. J Acquir Immune Defic Syndr Hum Retrovirol 1990, 3(7):658-668.
66. Podell M., Hayes K., Oglesbee M., et al. Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15(5):332-340.
67. Gruol D., Yu N., Parsons K.L., et al. Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. J Neurovirol 1998, 4(4):415-425.
68. Bragg D.C., Meeker R.B., Duff B.A., et al. Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures. Brain Res 1999, 816(2):431-437.
69. Beatty J., Terry A., MacDonald J., et al. Feline immunodeficiency virus integration in B-cell lymphoma identifies a candidate tumor suppressor gene on human chromosome 15q15. Cancer Res 2002, 62(24):7175-7180.
70. Hutson C.A., Rideout B.A., Pedersen N.C. Neoplasia associated with feline immunodeficiency virus-infection in cats of southern California. J Am Vet Med Assoc 1991, 199(10):1357-1362.
71. Callanan J.J., Mccandish I.A., O'Neil B., et al. Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Vet Rec 1992, 130(14):293-295.
72. Barr M.C., Butt M.T., Anderson K.L., et al. Spinal lymphosarcoma and disseminated mastocytoma associated with feline immunodeficiency virus infection in a cat. J Am Vet Med Assoc 1993, 202(12):1978-1980.
73. Poli A., Abramo F., Baldinotti F., et al. Malignant lymphoma associated with experimentally induced feline immunodeficiency virus infection. J Comp Pathol 1994, 110(4):319-328.
74. Shelton G.H., Grant C.K., Cotter S.M., et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr 1990, 3(6):623-630.
75. Gabor L.J., Love D.N., Malik R., et al. Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust Vet J 2001, 79(8):540-545.
76. Beatty J.A., Callanan J.J., Terry A., et al. Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation?. J Virol 1998, 72(1):767-771.
77. Dahoo I., Martin W., Stryhn H. Introduction and causal concepts. Veterinary epidemiologic research 2010, 1-23. VER Inc, Charlottetown (Canada). I. Dahoo, W. Martin, H. Stryhn (Eds.).
78. English R.V., Nelson P., Johnson C.M., et al. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 1994, 170(3):543-552.
79. George J.W., Pedersen N.C., Higgins J. The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res Hum Retroviruses 1993, 9(9):897-905.
80. Diehl L.J., Mathiason-Dubard C.K., O'Neil L.L., et al. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol 1995, 69(10):6149-6157.
81. Pedersen N.C., Leutenegger C.M., Woo J., et al. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats. Vet Immunol Immunopathol 2001, 79(1/2):53-67.
82. Hokanson R.M., TerWee J., Choi InSoo, et al. Dose response studies of acute feline immunodeficiency virus PPR strain infection in cats. Vet Microbiol 2000, 76(4):311-327.
83. Pecon-Slattery J., Troyer J.L., Johnson W.E., et al. Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology. Vet Immunol Immunopathol 2008, 123(1-2):32-44.
84. Troyer J.L., Pecon-Slattery J., Roelke M.E., et al. Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol 2005, 79(13):8282-8294.
85. Troyer J.L., VandeWoude S., Pecon-Slattery J., et al. FIV cross-species transmission: an evolutionary prospective. Vet Immunol Immunopathol 2008, 123(1-2):159-166.
86. Franklin S.P., Troyer J.L., Terwee J.A., et al. Frequent transmission of immunodeficiency viruses among bobcats and pumas. J Virol 2007, 81(20):10961-10969.
87. Driciru M., Siefert L., Prager K.C., et al. A serosurvey of viral infections in lions (Panthera leo), from Queen Elizabeth National Park, Uganda. J Wildl Dis 2006, 42(3):667-671.
88. Olmsted R.A., Langley R., Roelke M.E., et al. Worldwide prevalence of lentivirus infection in wild feline species: epidemiologic and phylogenetic aspects. J Virol 1992, 66(10):6008-6018.
89. Brown E.W., Miththapala S., O'Brien S.J. Prevalence of exposure to feline immunodeficiency virus in exotic felid species. J Zoo Wildlife Med 1993, 24(3):357-364.
90. Roelke M.E., Pecon-Slattery J., Taylor S., et al. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. Journal Wildl Dise 2006, 42(2):234-248.
91. Brown E.W., Yuhki N., Packer C., et al. A lion lentivirus related to feline immunodeficiency virus-epidemiologic and phylogenetic aspects. J Virol 1994, 68(9):5953-5968.
92. McEwan W.A., McMonagle E.L., Logan N., et al. Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors. J Virol 2008, 82(21):10953-10958.
93. Brennan G., Podell M.D., Wack R., et al. Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection. J Clin Microbiol 2006, 44(12):4345-4352.
94. Roelke M.E., Brown M.A., Troyer J.L., et al. Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology 2009, 390(1):1-12.
95. Brown M.A., Munkhtsog J.L., Troyer S., et al. Feline immunodeficiency virus (FIV) in wild Pallas' cats. Vet Immunol Immunop 2010, 134:90-95.